Report Summary
Novel Drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. NDDS is a system for delivery of drug other than conventional drug delivery system. NDDS is a combination of advance technique and new dosage forms which are far better than conventional dosage forms.
Advantages of Novel Drug Delivery System are: Optimum dose at the right time and right location, efficient use of expensive drugs, excipients and reduction in production cost, Beneficial to patients, better therapy, improved comfort and standard of living.
In 2020, the global Novel Drug Delivery Systems in Cancer Therapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2027, with a CAGR of xx% during 2021-2027.
This report focuses on the global Novel Drug Delivery Systems in Cancer Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Novel Drug Delivery Systems in Cancer Therapy development in United States, Europe and China.
The key players covered in this study
Teva
Johnson & Johnson
Roche
Takeda
AbbVie
Samyang Biopharmaceuticals
Celgene
Spectrum Pharmaceuticals, Inc.
Gilead Sciences
Shire (Baxalta)
Merrimack
Market segment by Type, the product can be split into
Nanoparticles
Liquid Embolics
Embolization Particles
Market segment by Application, split into
Hospitals & Clinic
Cancer Treatment Centers
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Novel Drug Delivery Systems in Cancer Therapy status, future forecast, growth opportunity, key market and key players.
To present the Novel Drug Delivery Systems in Cancer Therapy development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Novel Drug Delivery Systems in Cancer Therapy are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2020
Forecast Year 2021 to 2027
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table Of Contents
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Novel Drug Delivery Systems in Cancer Therapy Market Size Growth Rate by Type (2017-2027)
1.4.2 Nanoparticles
1.4.3 Liquid Embolics
1.4.4 Embolization Particles
1.5 Market by Application
1.5.1 Global Novel Drug Delivery Systems in Cancer Therapy Market Share by Application (2017-2027)
1.5.2 Hospitals & Clinic
1.5.3 Cancer Treatment Centers
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Novel Drug Delivery Systems in Cancer Therapy Market Size
2.2 Novel Drug Delivery Systems in Cancer Therapy Growth Trends by Regions
2.2.1 Novel Drug Delivery Systems in Cancer Therapy Market Size by Regions (2017-2027)
2.2.2 Novel Drug Delivery Systems in Cancer Therapy Market Share by Regions (2017-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Novel Drug Delivery Systems in Cancer Therapy Market Size by Manufacturers
3.1.1 Global Novel Drug Delivery Systems in Cancer Therapy Revenue by Manufacturers (2017-2020)
3.1.2 Global Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share by Manufacturers (2017-2020)
3.1.3 Global Novel Drug Delivery Systems in Cancer Therapy Market Concentration Ratio (CR5 and HHI)
3.2 Novel Drug Delivery Systems in Cancer Therapy Key Players Head office and Area Served
3.3 Key Players Novel Drug Delivery Systems in Cancer Therapy Product/Solution/Service
3.4 Date of Enter into Novel Drug Delivery Systems in Cancer Therapy Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Novel Drug Delivery Systems in Cancer Therapy Market Size by Type (2017-2020)
4.2 Global Novel Drug Delivery Systems in Cancer Therapy Market Size by Application (2017-2020)
5 United States
5.1 United States Novel Drug Delivery Systems in Cancer Therapy Market Size (2017-2020)
5.2 Novel Drug Delivery Systems in Cancer Therapy Key Players in United States
5.3 United States Novel Drug Delivery Systems in Cancer Therapy Market Size by Type
5.4 United States Novel Drug Delivery Systems in Cancer Therapy Market Size by Application
6 Europe
6.1 Europe Novel Drug Delivery Systems in Cancer Therapy Market Size (2017-2020)
6.2 Novel Drug Delivery Systems in Cancer Therapy Key Players in Europe
6.3 Europe Novel Drug Delivery Systems in Cancer Therapy Market Size by Type
6.4 Europe Novel Drug Delivery Systems in Cancer Therapy Market Size by Application
7 China
7.1 China Novel Drug Delivery Systems in Cancer Therapy Market Size (2017-2020)
7.2 Novel Drug Delivery Systems in Cancer Therapy Key Players in China
7.3 China Novel Drug Delivery Systems in Cancer Therapy Market Size by Type
7.4 China Novel Drug Delivery Systems in Cancer Therapy Market Size by Application
8 Japan
8.1 Japan Novel Drug Delivery Systems in Cancer Therapy Market Size (2017-2020)
8.2 Novel Drug Delivery Systems in Cancer Therapy Key Players in Japan
8.3 Japan Novel Drug Delivery Systems in Cancer Therapy Market Size by Type
8.4 Japan Novel Drug Delivery Systems in Cancer Therapy Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Novel Drug Delivery Systems in Cancer Therapy Market Size (2017-2020)
9.2 Novel Drug Delivery Systems in Cancer Therapy Key Players in Southeast Asia
9.3 Southeast Asia Novel Drug Delivery Systems in Cancer Therapy Market Size by Type
9.4 Southeast Asia Novel Drug Delivery Systems in Cancer Therapy Market Size by Application
10 India
10.1 India Novel Drug Delivery Systems in Cancer Therapy Market Size (2017-2020)
10.2 Novel Drug Delivery Systems in Cancer Therapy Key Players in India
10.3 India Novel Drug Delivery Systems in Cancer Therapy Market Size by Type
10.4 India Novel Drug Delivery Systems in Cancer Therapy Market Size by Application
11 Central & South America
11.1 Central & South America Novel Drug Delivery Systems in Cancer Therapy Market Size (2017-2020)
11.2 Novel Drug Delivery Systems in Cancer Therapy Key Players in Central & South America
11.3 Central & South America Novel Drug Delivery Systems in Cancer Therapy Market Size by Type
11.4 Central & South America Novel Drug Delivery Systems in Cancer Therapy Market Size by Application
12 International Players Profiles
12.1 Teva
12.1.1 Teva Company Details
12.1.2 Company Description and Business Overview
12.1.3 Novel Drug Delivery Systems in Cancer Therapy Introduction
12.1.4 Teva Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2017-2020)
12.1.5 Teva Recent Development
12.2 Johnson & Johnson
12.2.1 Johnson & Johnson Company Details
12.2.2 Company Description and Business Overview
12.2.3 Novel Drug Delivery Systems in Cancer Therapy Introduction
12.2.4 Johnson & Johnson Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2017-2020)
12.2.5 Johnson & Johnson Recent Development
12.3 Roche
12.3.1 Roche Company Details
12.3.2 Company Description and Business Overview
12.3.3 Novel Drug Delivery Systems in Cancer Therapy Introduction
12.3.4 Roche Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2017-2020)
12.3.5 Roche Recent Development
12.4 Takeda
12.4.1 Takeda Company Details
12.4.2 Company Description and Business Overview
12.4.3 Novel Drug Delivery Systems in Cancer Therapy Introduction
12.4.4 Takeda Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2017-2020)
12.4.5 Takeda Recent Development
12.5 AbbVie
12.5.1 AbbVie Company Details
12.5.2 Company Description and Business Overview
12.5.3 Novel Drug Delivery Systems in Cancer Therapy Introduction
12.5.4 AbbVie Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2017-2020)
12.5.5 AbbVie Recent Development
12.6 Samyang Biopharmaceuticals
12.6.1 Samyang Biopharmaceuticals Company Details
12.6.2 Company Description and Business Overview
12.6.3 Novel Drug Delivery Systems in Cancer Therapy Introduction
12.6.4 Samyang Biopharmaceuticals Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2017-2020)
12.6.5 Samyang Biopharmaceuticals Recent Development
12.7 Celgene
12.7.1 Celgene Company Details
12.7.2 Company Description and Business Overview
12.7.3 Novel Drug Delivery Systems in Cancer Therapy Introduction
12.7.4 Celgene Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2017-2020)
12.7.5 Celgene Recent Development
12.8 Spectrum Pharmaceuticals, Inc.
12.8.1 Spectrum Pharmaceuticals, Inc. Company Details
12.8.2 Company Description and Business Overview
12.8.3 Novel Drug Delivery Systems in Cancer Therapy Introduction
12.8.4 Spectrum Pharmaceuticals, Inc. Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2017-2020)
12.8.5 Spectrum Pharmaceuticals, Inc. Recent Development
12.9 Gilead Sciences
12.9.1 Gilead Sciences Company Details
12.9.2 Company Description and Business Overview
12.9.3 Novel Drug Delivery Systems in Cancer Therapy Introduction
12.9.4 Gilead Sciences Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2017-2020)
12.9.5 Gilead Sciences Recent Development
12.10 Shire (Baxalta)
12.10.1 Shire (Baxalta) Company Details
12.10.2 Company Description and Business Overview
12.10.3 Novel Drug Delivery Systems in Cancer Therapy Introduction
12.10.4 Shire (Baxalta) Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2017-2020)
12.10.5 Shire (Baxalta) Recent Development
12.11 Merrimack
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
